International projects

Based on Pharmnet’s long term presence on the market and well established strong network of the reliable partners, Pharmnet offers access to the whole European territory. Recently, we implement clinical study projects in Austria, Belarus, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Great Britain, Hungary, Italy, Latvia, Lithuania, Moldova, Netherlands, Norway, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland and Ukraine. Our European network comprises of more than 350 experienced employees.

Pharmnet, together with its partners, profit from our original ISO certified International Project Management approach based on careful planning, risk assessment and tracking all key parameters of the study through all participating countries (compliant with IPMA standards). Companies with a high level of local experience are, therefore, involved cooperating smoothly on the international level under a common set of procedures. The management system is regularly audited by TÜV Rheinland group (ISO recertification performed every year).

Smooth and fast implementations of the trials are also sustained through strong interpersonal relationships of the project managers. They know each other from the meetings conducted during common projects, as well as from the annual methodology meetings where the PM procedures are adjusted on the basis of practical field experience.

Cooperation model was validated by continuous cooperation on bilateral or multilateral projects in the past when delivered expected results to our clients.

In order to manage efficiently all activities Pharmnet with its partner may implement an online IT web platform that is 21 CFR part 11 compliant. This platform combines Trial Management System (for management of documents, monitoring activities and reports), IWRS (for randomization and patients visit tracking) and eCRF with patient records. All data from the platform can be exported in various reports through iReport feature. iReport is accessible to Sponsor as well allowing you to see continuously the progress of the trial (e.g. patients randomized per month/site/country etc., number of monitoring visits completed etc.) Key sections of the platform are adapted to study specific needs. E.g., in projects with tailor-made treatment, it is possible to design and implement a module that will allow logistics management ensuring that the flow of randomized patients will be in line with manufacturing capacities of our Sponsor. 

International projects

ISO Across Alliance
Czech biotech company Sotio started pIII trial for prostate cancer with their innovative imunotherapy product http://goo.gl/JDeRuZ 
LinkedIn
Pharmnet © 2017